Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36
Frequently Asked Questions
What is Market Cap of Enlivex Therapeutics Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enlivex Therapeutics Ltd market cap is $28.03M.
What is the 52-week high for Enlivex Therapeutics Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enlivex Therapeutics Ltd 52 week high is $2.10 as of October 10, 2025.
What is the 52-week low for Enlivex Therapeutics Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enlivex Therapeutics Ltd 52 week low is $0.8101 as of October 10, 2025.
What is Enlivex Therapeutics Ltd stock price today?
Enlivex Therapeutics Ltd stock price today is $1.17.
What was Enlivex Therapeutics Ltd stock price yesterday?
Enlivex Therapeutics Ltd stock price yesterday was $1.18.
What is the PE ratio of Enlivex Therapeutics Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enlivex Therapeutics Ltd’s P/E ratio is -2.08.
What is the Price-to-Book ratio of Enlivex Therapeutics Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enlivex Therapeutics Ltd P/B ratio is 1.4713.
What is the 50-day moving average of Enlivex Therapeutics Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enlivex Therapeutics Ltd 50-day moving average is $1.17.
How many employess does Enlivex Therapeutics Ltd has?